The transparency problem in this category
The cognitive supplement market frequently employs "proprietary blend" labeling — listing multiple ingredients under a single aggregate weight without individual dose disclosure. This practice, while legally permissible, prevents consumers from verifying whether any individual component is present at a clinically relevant dose.
Evaluation criteria
1. Individual dose disclosure. Absence of per-ingredient dosing prevents verification against published research thresholds.
2. Regulatory claim compliance. Claims to "cure," "reverse," or "treat" a diagnosed condition such as Alzheimer's disease exceed what is legally permissible for a dietary supplement in the United States.
3. Mechanistic coherence. A formulation should be explicable in terms of a defined physiological mechanism, not a list of trend-driven ingredient names.
4. Guarantee structure. A refund window under 30 days, or one requiring unopened product, is structurally incompatible with fair evaluation of a cumulative-effect supplement.
5. Manufacturer transparency. A verifiable manufacturing facility and accessible support channel are baseline indicators of legitimacy.
Markers of a well-formulated product
Full ingredient disclosure with individual amounts. A limited ingredient set built around a defined, explicable mechanism. Manufacturing in an FDA-registered, GMP-certified facility. A guarantee period of 60 days or more, inclusive of opened product.
Evaluation heuristic: A well-formulated product's manufacturer should be able to articulate, for each ingredient, its dose rationale relative to published research.
Formulation density versus formulation breadth
A limited set of ingredients dosed at clinically relevant levels, addressing complementary mechanisms, is generally preferable to an extensive ingredient list diluted across a fixed cost basis at sub-therapeutic doses per component.
Guarantee terms as a confidence signal
Refund policy structure often correlates with manufacturer confidence in product efficacy. Review whether the guarantee period begins at the purchase date or delivery date, and whether a minimum usage period is required prior to evaluation — a structure requiring 30 days minimum use, with a 60-day claim window, reflects an evidence-informed understanding of cumulative supplement effects.
A concise evaluation test
Before purchase, evaluate whether the formulation's rationale can be articulated in two sentences. A label populated with unexplained proprietary terminology, absent individual dosing, typically indicates a marketing-first rather than formulation-first development process.
Regulatory context for this category
The dietary supplement category for cognitive support has an established history of FDA warning letters addressing unsubstantiated disease claims and FTC enforcement actions related to deceptive advertising practices. This regulatory history does not indicate universal non-compliance, but it does support a baseline level of consumer diligence when evaluating claims in this specific product category, particularly around language implying treatment of diagnosed neurological conditions.
Direct manufacturer inquiry as a diligence step
A practical evaluation step involves contacting manufacturer support directly with specific questions: what published research supports each ingredient at the labeled dose, what facility certifications apply to manufacturing, and what the guarantee terms specifically cover. Response quality and specificity to these questions is itself informative regarding formulation rigor.
Price as an unreliable quality proxy
Retail price correlates weakly with formulation quality in this product category. Marketing expenditure and distribution costs contribute substantially to price without corresponding to ingredient dose or sourcing quality. Evaluation should proceed from the label and guarantee terms directly rather than from price positioning as a quality signal.
Six Nutrients, One Daily Capsule
Stimulant-free. Non-GMO. FDA-registered facility. 60-day guarantee.
View Pricing